← Open Payments lookup

KELLIE VAUGHN: Open Payments

NPI 1245705698 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,825 in 91 payments from 12 companies in 2025. Trend: 2023 $1,814 · 2024 $995 · 2025 $1,825

Food & beverage: $1,825
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$583
Otsuka America Pharmaceutical, Inc.11$251
ABBVIE INC.22$244
Vanda Pharmaceuticals Inc.6$151
E.R. Squibb & Sons, L.L.C.5$113
Axsome Therapeutics, Inc.4$109
Lundbeck LLC4$98
Takeda Pharmaceuticals U.S.A., Inc.4$76
Neurocrine BioSciences, Inc.3$66
Alkermes, Inc.3$63

Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, COBENFY, Auvelity, TRINTELLIX, INGREZZA.

Industry payments across AL — which companies pay providers there.